Lexeo Therapeutics, Inc.

LXEO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G Oct 13, 2026
8-K Sep 29, 2026 8-K
4 Sep 28, 2026
4 Sep 28, 2026
4 Sep 28, 2026
4 Sep 28, 2026
8-K Sep 22, 2026 8-K
4 Aug 19, 2026
4 Aug 19, 2026
4 Aug 19, 2026
144 Aug 18, 2026
144 Aug 18, 2026
144 Aug 18, 2026
SCHEDULE 13G Aug 14, 2026
SCHEDULE 13G/A Aug 14, 2026
SCHEDULE 13G/A Aug 14, 2026
SCHEDULE 13G/A Aug 13, 2026
10-Q Aug 12, 2026 10-Q
8-K Aug 12, 2026 8-K
SCHEDULE 13G Aug 7, 2026
4 Jul 1, 2026
4 Jul 1, 2026
4 Jul 1, 2026
4 Jul 1, 2026
144 Jul 1, 2026
← Newer Page 1 of 15 · 359 filings Older →